Gene · 64115
Papers2,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustion. | Biomed Pharmacother | 2026 | 41793972 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. | Curr Oncol Rep | 2026 | 41790359 | PubTator, text mining | PubMed |
| Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer. | J Immunother Cancer | 2026 | 41781018 | PubTator, text mining | PubMed |
| Poliovirus receptor (PVR) expression as a predictor of relapse in colorectal cancer: bioinformatics and virtual screening. | Exp Biol Med (Maywood) | 2026 | 41767749 | PubTator, text mining | PubMed |
| Identification of multigene predictors of prognosis in patients with ovarian cancer. | iScience | 2026 | 41767263 | PubTator, text mining | PubMed |
| Sex Differences in Cancer Immunotherapy-Clinical Evidence and Mechanisms With a Focus on NSCLC. | Immunol Rev | 2026 | 41761458 | PubTator, text mining | PubMed |
| Predicting skin melanoma progression via LAG-3, TIGIT and HAVCR2. | Funct Integr Genomics | 2026 | 41746432 | PubTator, text mining | PubMed |
| Targeting Telomerase in Cancer: Vaccine-Based Strategies, Clinical Evidence, and Synergy with Immunotherapy. | Diseases | 2026 | 41745118 | PubTator, text mining | PubMed |
| Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as an Isolated Oral Manifestation. | Dent J (Basel) | 2026 | 41744967 | PubTator, text mining | PubMed |
| Overcoming Immunotherapy Resistance in Small-Cell Lung Cancer. | Biology (Basel) | 2026 | 41744665 | PubTator, text mining | PubMed |
| First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours. | BMJ Oncol | 2026 | 41737913 | PubTator, text mining | PubMed |
| Diversity and function of tumor-associated macrophages in brain metastases: mechanisms and therapeutic prospects. | Front Immunol | 2026 | 41727473 | PubTator, text mining | PubMed |
| The tumor microenvironment in leukemia: molecular pathways of immune evasion. | Front Immunol | 2026 | 41727472 | PubTator, text mining | PubMed |
| The tumor microenvironment in hematologic malignancies: immune evasion, metabolic reprogramming, and therapeutic resistance. | Blood Sci | 2026 | 41726040 | PubTator, text mining | PubMed |
| Distinct immune microenvironments in ovarian cancer subtypes indicate potential for immunotherapies. | J Transl Med | 2026 | 41723536 | PubTator, text mining | PubMed |
| Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss. | Sci Adv | 2026 | 41719400 | PubTator, text mining | PubMed |
| Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer. | JCO Precis Oncol | 2026 | 41712875 | PubTator, text mining | PubMed |
| Spatial single-cell analysis reveals tumor microenvironment signatures predictive of oral cavity cancer outcome. | Cell Rep Med | 2026 | 41707652 | PubTator, text mining | PubMed |
| Sex Hormones-Mediated Modulation of Immune Checkpoints in Pregnancy and Recurrent Pregnancy Loss. | Int J Mol Sci | 2026 | 41683692 | PubTator, text mining | PubMed |
| VISTA: bridging gaps in cancer immunotherapy. | Discov Oncol | 2026 | 41665763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64115/papers?page=4